Join
Live feed
·
PRReleasevia Quantisnow
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market

ByQuantisnow·Wall Street's wire, on your screen.
INBS· Intelligent Bio Solutions Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INBS (Intelligent Bio Solutions Inc.) and more on Quantisnow.